Related Experiment Video
Updated: Jul 9, 2026
13:12
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain Mapping
Published on: August 12, 2019
Primary progressive aphasia: a 25-year retrospective.
1Cognitive Neurology and Alzheimer's Disease Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. mmesulam@northwestern.edu
Alzheimer Disease and Associated Disorders
|December 20, 2007
Summary
Primary progressive aphasia (PPA) is a neurodegenerative condition where language impairment is the primary symptom. Diagnosis focuses on this selective language decline, distinguishing it from other cognitive disorders.
Area of Science:
- Neurology
- Linguistics
- Neurodegeneration
Background:
- Primary progressive aphasia (PPA) is defined by a neurodegenerative cause of progressive language impairment as the most prominent clinical feature.
- PPA subtypes include progressive nonfluent aphasia and certain semantic dementia types.
- Recent advancements have significantly improved understanding of PPA's neurolinguistics, neuroanatomy, and genetics.
Observation:
- PPA presents with fluent or nonfluent aphasia, with variable impact on word comprehension.
- Recent memory is relatively preserved, though verbal memory tests may show deficits.
- Behavioral and object recognition changes are secondary and not the primary reason for medical consultation.
Findings:
- The diagnosis of PPA hinges on language deficits being the most salient clinical manifestation.
- PPA's distinct clinical pattern is most evident in the early stages of the disease.
- Research is rapidly evolving across multiple domains including imaging, neuropathology, and risk factors.
Implications:
- Accurate PPA diagnosis is crucial for appropriate patient management and therapeutic strategies.
- Understanding PPA's selective neurodegeneration aids in differentiating it from other dementia syndromes.
- Continued research into PPA's multifaceted aspects promises improved diagnostic and therapeutic outcomes.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:24Prosopagnosia
Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
01:17Introduction to Language of Pathophysiology ll
This lesson explores key terms that describe how diseases progress, their outcomes, and their distribution in populations.Diagnostic tests identify diseases and monitor treatment. These include blood and urine tests, biopsies, imaging (X-ray, MRI), and detection of infectious agents.Remission is a reduction or disappearance of symptoms.Exacerbation refers to the worsening of symptoms, such as increased wheezing during an asthma attack.A precipitating factor triggers an acute episode, while a...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...